226 related articles for article (PubMed ID: 31556714)
1. Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral α
Turunen H; Raekallio MR; Honkavaara JM; Restitutti F; Kallio-Kujala IJ; Adam M; Nevanperä K; Scheinin M; Männikkö SK; Hautajärvi HJ; Larenza Menzies P; Vainio OM
Am J Vet Res; 2019 Oct; 80(10):912-922. PubMed ID: 31556714
[TBL] [Abstract][Full Text] [Related]
2. Sedative effect of intramuscular medetomidine with and without vatinoxan (MK-467), and its reversal with atipamezole in sheep.
Adam M; Raekallio MR; Vainio OM
Vet Anaesth Analg; 2018 Nov; 45(6):788-793. PubMed ID: 30301665
[TBL] [Abstract][Full Text] [Related]
3. Effects of intramuscular vatinoxan (MK-467), co-administered with medetomidine and butorphanol, on cardiopulmonary and anaesthetic effects of intravenous ketamine in dogs.
Turunen H; Raekallio M; Honkavaara J; Jaakkola J; Scheinin M; Männikkö S; Hautajärvi H; Bennett R; Vainio O
Vet Anaesth Analg; 2020 Sep; 47(5):604-613. PubMed ID: 32682664
[TBL] [Abstract][Full Text] [Related]
4. Effects of the peripherally acting α
Adam M; Raekallio MR; Salla KM; Honkavaara JM; Männikkö S; Scheinin M; Kajula M; Mölsä SH; Vainio OM
Am J Vet Res; 2018 Sep; 79(9):921-932. PubMed ID: 30153057
[TBL] [Abstract][Full Text] [Related]
5. The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol.
Salla K; Restitutti F; Vainionpää M; Junnila J; Honkavaara J; Kuusela E; Raekallio M; Vainio O
Vet Anaesth Analg; 2014 Nov; 41(6):567-74. PubMed ID: 24674053
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of premedication with medetomidine alone and in combination with MK-467 or glycopyrrolate in dogs subsequently anesthetized with isoflurane.
Salla KM; Tuns CI; Bennett RC; Raekallio MR; Scheinin M; Kuusela E; Vainio OM
Am J Vet Res; 2017 Nov; 78(11):1245-1254. PubMed ID: 29076369
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha
Restitutti F; Kaartinen MJ; Raekallio MR; Wejberg O; Mikkola E; Del Castillo JRE; Scheinin M; Vainio OM
Vet Anaesth Analg; 2017 May; 44(3):417-426. PubMed ID: 28552594
[TBL] [Abstract][Full Text] [Related]
8. Effects of vatinoxan on cardiorespiratory function, fecal output and plasma drug concentrations in horses anesthetized with isoflurane and infusion of medetomidine.
Tapio HA; Raekallio MR; Mykkänen AK; Al-Ramahi D; Scheinin M; Hautajärvi HJ; Männikkö S; Vainio O
Vet J; 2019 Sep; 251():105345. PubMed ID: 31492389
[TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary and sedative effects of the peripheral α2-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs.
Rolfe NG; Kerr CL; McDonell WN
Am J Vet Res; 2012 May; 73(5):587-94. PubMed ID: 22533388
[TBL] [Abstract][Full Text] [Related]
10. The impact of MK-467 on plasma drug concentrations, sedation and cardiopulmonary changes in sheep treated with intramuscular medetomidine and atipamezole for reversal.
Adam M; Raekallio MR; Keskitalo T; Honkavaara JM; Scheinin M; Kajula M; Mölsä S; Vainio OM
J Vet Pharmacol Ther; 2018 Jun; 41(3):447-456. PubMed ID: 29352473
[TBL] [Abstract][Full Text] [Related]
11. Effects of vatinoxan on cardiorespiratory function and gastrointestinal motility during constant-rate medetomidine infusion in standing horses.
Tapio H; Raekallio MR; Mykkänen A; Männikkö S; Scheinin M; Bennett RC; Vainio O
Equine Vet J; 2019 Sep; 51(5):646-652. PubMed ID: 30793362
[TBL] [Abstract][Full Text] [Related]
12. Comparison between dexmedetomidine and a combination of medetomidine-vatinoxan on muscle tissue saturation in privately-owned adult dogs undergoing intradermal testing.
McKenzie SR; Chiavaccini L; Moura RA; Santoro D
Res Vet Sci; 2024 May; 171():105207. PubMed ID: 38460204
[TBL] [Abstract][Full Text] [Related]
13. Peripheral α
Kallio-Kujala IJ; Raekallio MR; Honkavaara J; Bennett RC; Turunen H; Scheinin M; Hautajärvi H; Vainio O
Vet Anaesth Analg; 2018 Jul; 45(4):405-413. PubMed ID: 29891212
[TBL] [Abstract][Full Text] [Related]
14. Peripherally acting α-adrenoceptor antagonist MK-467 with intramuscular medetomidine and butorphanol in dogs: A prospective, randomised, clinical trial.
Kallio-Kujala IJ; Turunen HA; Raekallio MR; Honkavaara JM; Salla KM; Casoni D; Hautajärvi HJ; Vainio OM
Vet J; 2018 Oct; 240():22-26. PubMed ID: 30268328
[TBL] [Abstract][Full Text] [Related]
15. Sedative and cardiopulmonary effects of medetomidine hydrochloride and xylazine hydrochloride and their reversal with atipamezole hydrochloride in calves.
Rioja E; Kerr CL; Enouri SS; McDonell WN
Am J Vet Res; 2008 Mar; 69(3):319-29. PubMed ID: 18312129
[TBL] [Abstract][Full Text] [Related]
16. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs.
Pagel PS; Proctor LT; Devcic A; Hettrick DA; Kersten JR; Tessmer JP; Farber NE; Schmeling WT; Warltier DC
J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):429-34. PubMed ID: 9713732
[TBL] [Abstract][Full Text] [Related]
17. Sedative and cardiopulmonary effects of buccally administered detomidine gel and reversal with atipamezole in dogs.
Kasten JI; Messenger KM; Campbell NB
Am J Vet Res; 2018 Dec; 79(12):1253-1260. PubMed ID: 30457910
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of medetomidine enantiomers and vatinoxan, an α
Honkavaara JM; Raekallio MR; Syrja PM; Pypendop BH; Knych HK; Kallio-Kujala IJ; Vainio OM
Vet Anaesth Analg; 2020 Jan; 47(1):47-52. PubMed ID: 31761600
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the effects of vatinoxan on somatic and visceral antinociceptive efficacy of medetomidine in dogs.
Huuskonen V; Restitutti F; Honkavaara JM; Raekallio MR; Männikkö S; Scheinin M; Vainio OM
Am J Vet Res; 2020 Apr; 81(4):299-308. PubMed ID: 32228259
[TBL] [Abstract][Full Text] [Related]
20. Influence of ketamine on the cardiopulmonary effects of intramuscular administration of dexmedetomidine-buprenorphine with subsequent reversal with atipamezole in dogs.
Ko JC; Barletta M; Sen I; Weil AB; Krimins RA; Payton ME; Constable P
J Am Vet Med Assoc; 2013 Feb; 242(3):339-45. PubMed ID: 23327175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
